Who are Plegisol In Plastic Container's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Plegisol In Plastic Container, Met097, Other treatment, PF-06863135 monotherapy IV or SC, deep block, BNT162b2 vaccine.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/bacteriostatic-sodium-chloride-0-9-in-plastic-container.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Plegisol In Plastic Container — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Plegisol In Plastic Container (Sodium Chloride) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte solution.

marketed Electrolyte solution Not specified Small molecule Live · refreshed every 30 min

Target snapshot

Plegisol In Plastic Container (Sodium Chloride) — Baxter. Provides isotonic saline irrigation with mechanical cleansing action for sterile irrigation of body cavities, tissues, wounds, and surgical equipment.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Plegisol In Plastic Container TARGET	Sodium Chloride	Baxter	marketed	Electrolyte solution	Not specified	1965-01-01
Plegisol In Plastic Container	Sodium Chloride	Baxter	marketed	Electrolyte solution	Not specified	1965-01-01
Met097	met097	Pfizer	marketed	Not specified	Not specified
Other treatment	Other treatment	Novartis Pharmaceuticals	marketed	Not specified	Not specified
PF-06863135 monotherapy IV or SC	pf-06863135-monotherapy-iv-or-sc	Pfizer Inc.	marketed	Not specified	Not specified
deep block	deep block	Seoul National University Bundang Hospital	marketed	The drug class of deep block is not clearly defined.	The specific target or pathway that deep block aims to modulate is not specified.
BNT162b2 vaccine	BNT162b2 vaccine	Vaxxinity, Inc.	marketed	Not specified	Not specified

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte solution class)

Baxter · 2 drugs in this class
Assistance Publique - Hôpitaux de Paris · 1 drug in this class
Pfizer Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Plegisol In Plastic Container — Competitive Intelligence Brief. https://druglandscape.com/ci/bacteriostatic-sodium-chloride-0-9-in-plastic-container. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab